Abuse-resistant amphetamine prodrugs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7659253
APP PUB NO 20090234002A1
SERIAL NO

12131923

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention describes compounds, compositions, and methods of using the same comprising a chemical moiety covalently attached to amphetamine. These compounds and compositions are useful for reducing or preventing abuse and overdose of amphetamine. These compounds and compositions find particular use in providing an abuse-resistant alternative treatment for certain disorders, such as attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity. Oral bioavailability of amphetamine is maintained at therapeutically useful doses. At higher doses bioavailability is substantially reduced, thereby providing a method of reducing oral abuse liability. Further, compounds and compositions of the invention decrease the bioavailability of amphetamine by parenteral routes, such as intravenous or intranasal administration, further limiting their abuse liability.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITEDOSAKA-SHI OSAKA 541-0045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bishop, Barney Annandale, US 72 927
Krishnan, Suma Belvedere, US 97 1593
Lauderback, Christopher Blacksburg, US 67 1465
Mickle, Travis Coralville, US 159 2039
Moncrief, James Scott Christiansburg, US 74 1566
Oberlender, Robert Blacksburg, US 53 618
Paul, Bernhard J Lexington, US 58 691
Piccariello, Thomas Blacksburg, US 91 1751
Verbicky, Christopher A Broadalbin, US 51 654

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation